Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Graefe's Archive for Clinical and Experimental Ophthalmology
Erschienen in:

07.12.2018 | Retinal Disorders

Vascular remodeling of choroidal neovascularization in older myopic patients treated with ranibizumab

verfasst von: Salomon Y. Cohen, Sandrine Tabary, Ala El Ameen, Sarah Mrejen, Gabriel Quentel, Audrey Giocanti-Auregan

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate morphological changes in myopic choroidal neovascularization (mCNV) using optical coherence tomography-angiography (OCT-A) after treatment with ranibizumab.

Methods

Retrospective analysis of consecutive patients over a 24-month period. All treatment-naïve mCNV were imaged at baseline with color pictures, spectral-domain OCT and OCT-A, and fluorescein angiography in selected cases. CNV morphology was classified at baseline and at 6 months. The CNV lesion surface was also compared.

Results

Twenty-nine patients with a mean age of 70.3 ± 10.1 years were included. They received a mean number of 2.65 injections over 6 months. Best-corrected visual acuity improved from 62.2 to 68.5 letters (p = 0.004), with regression of exudation in 24 eyes (82.7%). Baseline CNV was classified into tree-in-bud (16 eyes), medusa (9 eyes), or sea-fan (4 eyes) pattern. At 6 months, no abnormal blood flow was observed in CNV in 13 eyes. Eyes with complete regression or evolution towards an indistinct pattern showed more often a complete regression of exudation than eyes with unchanged pattern (p = 0.007). The mean CNV surface significantly decreased from 0.19 to 0.08 mm2 (p < 0.0001).

Conclusion

An unchanged pattern was more often associated with exudation persistence, while a complete regression or evolution towards indistinct pattern was always associated with vascular inactivity. However, variable changes in mCNV were observed after anti-VEGF. Thus, OCT-A could be more useful in the diagnosis than in the follow-up of mCNV.
Literatur
1.
Hotchkiss ML, Fine SL (1981) Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 91:177–183CrossRefPubMed
2.
Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P (2014) Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 157:9–25CrossRefPubMed
3.
Neelam K, Cheung CM, Ohno-Matsui K, Lai TY, Wong TY (2012) Choroidal neovascularization in pathological myopia. Prog Retin Eye Res 31:495–525CrossRefPubMed
4.
5.
Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas G (1996) Etiology of choroidal neovascularization in young patients. Ophthalmology 103:1241–1244CrossRefPubMed
6.
Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, Tokoro T, Mochizuki M (2003) Myopic choroidal neovascularization: a 10 year follow-up. Ophthalmology 110:1297–1305CrossRefPubMed
7.
Leveziel N, Caillaux V, Bastuji-Garin S, Zmuda M, Souied EH (2013) Angiographic and optical coherence tomography characteristics of recent myopic choroidal neovascularization. Am J Ophthalmol 155:913–919CrossRefPubMed
8.
Ores R, Puche N, Querques G, Blanco-Garavito R, Merle B, Coscas G, Oubraham H, Semoun O, Souied EH (2014) Gray hyper-reflective subretinal exudative lesions in exudative age-related macular degeneration. Am J Ophthalmol 158:354–361CrossRefPubMed
9.
Dansingani KK, Tan AC, Gilani F, Phasukkijwatana N, Novais E, Querques L, Waheed NK, Duker JS, Querques G, Yannuzzi LA, Sarraf D, Freund KB (2016) Subretinal hyperreflective material imaged with optical coherence tomography angiography. Am J Ophthalmol 169:235–248CrossRefPubMed
10.
Bruyère E, Caillaux V, Cohen SY, Martiano D, Ores R, Puche N, Souied EH (2015) Spectral-domain optical coherence tomography of subretinal hyperreflective exudation in myopic choroidal neovascularization. Am J Ophthalmol 160:749–758CrossRefPubMed
11.
Puliafito CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, Izatt JA, Swanson EA, Fujimoto JG (1995) Imaging of macular diseases with optical coherence tomography. Ophthalmology 102:217–229CrossRefPubMed
12.
Hee MR, Baumal CR, Puliafito CA, Duker JS, Reichel E, Wilkins JR, Coker JG, Schuman JS, Swanson EA, Fujimoto JG (1996) Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 103:1260–1270CrossRefPubMed
13.
Rosenfeld PJ (2016) Optical coherence tomography and the development of antiangiogenic therapies in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 57:OCT14–OCT26CrossRefPubMedPubMedCentral
14.
de Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Duker JS, Waheed NK (2015) Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 122:1228–1238CrossRefPubMed
15.
El Ameen A, Cohen SY, Semoun O, Miere A, Srour M, Quaranta-El Maftouhi M, Oubraham H, Blanco-Garavito R, Querques G, Souied EH (2015) Type 2 neovascularization secondary to age related macular degeneration imaged by optical coherence tomography angiography. Retina 35:2212–2218CrossRefPubMed
16.
Bruyère E, Miere A, Cohen SY, Martiano D, Sikorav A, Popeanga A, Semoun O, Querques G, Souied EH (2017) Neovascularization secondary to high myopia imaged by optical coherence tomography angiography. Retina 37:2095–2101CrossRefPubMed
17.
Querques L, Giuffrè C, Corvi F, Zucchiatti I, Carnevali A, De Vitis LA, Querques G, Bandello F (2017) Optical coherence tomography angiography of myopic choroidal neovascularisation. Br J Ophthalmol 101:609–615CrossRefPubMed
18.
Miere A, Butori P, Cohen SY, Semoun O, Capuano V, Jung C, Souied EH (2017) Vascular remodeling of choroidal neovascularization after anti-vascular endothelial growth factor therapy visualized on optical coherence tomography angiography. Retina Nov 23
19.
Coscas GJ, Lupidi M, Coscas F, Cagini C, Souied EH (2015) Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration: a new diagnostic challenge. Retina 35:2219–2228CrossRefPubMed
20.
Liang MC, de Carlo TE, Baumal CR, Reichel E, Waheed NK, Duker JS, Witkin AJ (2016) Correlation of spectral domain optical coherence tomography angiography and clinical activity in neovascular age-related macular degeneration. Retina 36:2265–2273CrossRefPubMed
21.
22.
Wolf S, Balciuniene VJ, Laganovska G, Menchini U, Ohno-Matsui K, Sharma T, Wong TY, Silva R, Pilz S, Gekkieva M, RADIANCE Study Group (2014) RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 121:682–692CrossRefPubMed
23.
Ohno-Matsui K, Kawasaki R, Jonas JB, Ohno-Matsui K, Kawasaki R, Jonas JB, Cheung CM, Saw SM, Verhoeven VJ, Klaver CC, Moriyama M, Shinohara K, Kawasaki Y, Yamazaki M, Meuer S, Ishibashi T, Yasuda M, Yamashita H, Sugano A, Wang JJ, Mitchell P, Wong TY, META-analysis for Pathologic Myopia (META-PM) Study Group (2015) International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 159:877–883CrossRefPubMed
24.
Ikuno Y, Ohno-Matsui K, Wong TY, Korobelnik JF, Vitti R, Li T, Stemper B, Asmus F, Zeitz O, Ishibashi T, Investigators MYRROR (2015) Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology 122:1220–1227CrossRefPubMed
25.
Karagiannis D, Kontadakis GA, Kaprinis K, Giarmoukakis A, Georgalas I, Parikakis EA, Tsilimbaris MK (2017) Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age. Clin Ophthalmol 11:1197–1201CrossRefPubMedPubMedCentral
26.
Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M (2002) Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 109:712–719CrossRefPubMed
27.
Cohen SY, Nghiem-Buffet S, Grenet T, Dubois L, Ayrault S, Fajnkuchen F, Delahaye-Mazza C, Quentel G, Tadayoni R (2015) Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumab. Jpn J Ophthalmol 59:36–42CrossRefPubMed
28.
Yang HS, Kim JG, Kim JT, Joe SG (2013) Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab. Am J Ophthalmol 156:1201–1210CrossRefPubMed
29.
Lai TY, Luk FO, Lee GK, Lam DS (2012) Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization. Eye (Lond) 26:1004–1011CrossRef
30.
Ruiz-Moreno JM, Montero JA, Araiz J, Arias L, García-Layana A, Carneiro A, Figueroa MS, Silva R (2015) Intravitreal antivascular endothelial growth factor therapy for choroidal neovascularization secondary to pathologic myopia: six years outcome. Retina 35:2450–2456CrossRefPubMed
31.
Oishi A, Yamashiro K, Tsujikawa A, Ooto S, Tamura H, Nakata I, Miyake M, Yoshimura N (2013) Long-term effect of intravitreal injection of anti VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 251:1–7CrossRefPubMed
32.
Gharbiya M, Cruciani F, Mariotti C, Grandinetti F, Marenco M, Cacace V (2015) Choroidal thickness changes after intravitreal antivascular endothelial growth factor therapy for age-related macular degeneration: ranibizumab versus aflibercept. J Ocul Pharmacol Ther 31:357–362CrossRefPubMed
33.
Kim JH, Lee TG, Chang YS, Kim CG, Cho SW (2016) Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study. Br J Ophthalmol 100:1634–1639CrossRefPubMed
34.
Leveziela N, Quaranta-El Maftouhib M, Lalloumc F, Souied É, Cohen SY, Fédération France Macula (2014) Treatment of myopic choroidal neovascularization: recommendations of the Fédération France Macula. J Fr Ophtalmol 37:320–328CrossRefPubMed
35.
Cohen SY, Mrejen S (2017) Imaging of exudative age-related macular degeneration: toward a shift in the diagnostic paradigm? Retina 37:1625–1626CrossRefPubMed
36.
Miyata M, Ooto S, Hata M, Yamashiro K, Tamura H, Akagi-Kurashige Y, Nakanishi H, Ueda-Arakawa N, Takahashi A, Kuroda Y, Wakazono T, Yoshikawa M, Yoshimura N (2016) Detection of myopic choroidal neovascularization using optical coherence tomography angiography. Am J Ophthalmol 165:108–114CrossRefPubMed
37.
Ploner SB, Moult EM, Choi W, Waheed NK, Lee B, Novais EA, Cole ED, Potsaid B, Husvogt L, Schottenhamml J, Maier A, Rosenfeld PJ, Duker JS, Hornegger J, Fujimoto JG (2016) Toward quantitative optical coherence tomography angiography: visualizing blood flow speeds in ocular pathology using variable interscan time analysis. Retina 36(Suppl 1):S118–S126CrossRefPubMedPubMedCentral
38.
Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, Potsaid B, Liu JJ, Lu CD, Kraus MF, Fujimoto JG, Huang D (2014) Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 121:1435–1444CrossRefPubMedPubMedCentral
39.
Liu B, Bao L, Zhang J (2016) Optical coherence tomography angiography of pathological myopia sourced and idiopathic choroidal neovascularization with follow-up. Medicine (Baltimore) 95:e3264CrossRef
Metadaten
Titel
Vascular remodeling of choroidal neovascularization in older myopic patients treated with ranibizumab
verfasst von
Salomon Y. Cohen
Sandrine Tabary
Ala El Ameen
Sarah Mrejen
Gabriel Quentel
Audrey Giocanti-Auregan
Publikationsdatum
07.12.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 3/2019
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-04205-x

Weitere Artikel der Ausgabe 3/2019

Effects of posterior scleral reinforcement in pathological myopia: a 3-year follow-up study

  • Refractive Surgery

Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations

  • Review Article

Depressive symptoms, resilience, and personality traits in dry eye disease

  • Cornea

Evaluation of retinal vasculature before and after treatment of children with obstructive sleep apnea-hypopnea syndrome by optical coherence tomography angiography

  • Retinal Disorders

Development of a novel noninvasive system for measurement and imaging of the arterial phase oxygen density ratio in the retinal microcirculation

  • Retinal Disorders

Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study

  • Open Access
  • Retinal Disorders

Neu im Fachgebiet Augenheilkunde

Zirkulierende Tumorzellen bei uvealem Melanom

Die Erstbeschreibung von Tumorzellen in der Blutbahn erfolgte 1869 durch Thomas Ashworth. Dieser beschrieb in der Blutprobe eines metastasierten Krebskranken „cells identical with those of the cancer itself“ und postulierte, dass diese „may tend …

Elektrophysiologie in der Augenheilkunde

Mit elektrophysiologischen Untersuchungen kann man in der Augenheilkunde die Funktionalität der Neurone der Sehbahn untersuchen. Weil elektrophysiologische Ableitungen von der subjektiven Wahrnehmung und Antwort des Patienten unabhängig sind …

„Liquid biopsy“ bei Retinoblastom

Die „liquid biopsy“ spielt eine zunehmend wichtige Rolle bei der Diagnose und Behandlung des Retinoblastoms. Die Möglichkeit der sicheren und unkomplizierten Entnahme und Untersuchung von Kammerwasser aus der Vorderkammer trägt wesentlich zur …

Die „onkologische Spur“: zirkulierende Tumor-DNA beim Aderhautmelanom

In Körperflüssigkeiten wurde zirkulierende Desoxyribonukleinsäure (DNA) bereits vor mehr als 75 Jahren beschrieben [ 19 ]. Aber erst durch die eindrucksvolle technische Weiterentwicklung im Bereich der Nukleinsäureanalyse in den letzten Jahren ist …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen